APGE vs GE · $2.34B cap vs P/E 44, rev $13.35B
Apogee Therapeutics, Inc. Common Stock (APGE) versus GE Aerospace (GE) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
APGE does not have a complete income-statement cache yet.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
APGE currently screens at market cap $2.34B. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Not investment advice. Open the APGE and GE stock pages for the full models.
Not investment advice.